
Technical analysis of Grifols, S.A. (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.
Grifols, S.A. is a healthcare company engaged in the research, development, production, and marketing of plasma-derived medicines. The company operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others, offering hemoderivatives for various therapeutic areas, diagnostic testing equipment and reagents, biological products for pharmaceutical and biotech companies, and healthcare solutions for hospitals including intravenous solutions, clinical nutrition, and medical devices.
Description generated automatically from public sources; it may be inaccurate or out of date.
Closing values for October 16, 2026, computed on the last 12 months of prices.
21 sessions
9.72 €
+4.87%
50 sessions
9.83 €
+3.71%
200 sessions
9.68 €
+5.23%
s2
9.69
Support
s1
9.89
Support
pivot
10.01
Pivot
r1
10.21
Resistance
r2
10.33
Resistance
In the October 16, 2026 session Grifols, S.A. closed higher at 10.19 €, +0.99% versus the previous session.
The price sits above every moving average observed: +4.87% against the 21-session average, +3.71% against the 50 and +5.23% against the 200.
The 14-period RSI reads 60.7, in neutral territory.
MACD stands at 0.077 against a signal line at 0.021: the histogram is positive (+0.057).
ADX reads 13.4, indicating weak directionality.
Levels computed on the latest session place supports at 9.89 and 9.69 € and resistances at 10.21 and 10.33 €, around a pivot of 10.01.
The average daily range (ATR) is 0.231 €, or 2.27% of price.
Turnover was 465K shares, 37% of the 20-session average.
Over the last twelve months the price ranged between 8.54 and 10.80 €, and today stands −5.69% from the period high.
Measures computed on closing prices. They describe the past; they are not forecasts.
Score, Elliott Waves, moving averages and technical indicators — free, no card
If you're not registered we'll ask you to sign in (free), then open the GRF.MC analysis.
Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.
Elliott Waves
Wave counting to frame the price structure.
MTF moving averages
Moving averages across timeframes to read the trend.
0–100 score
A technical summary of the setup, updated daily.
How is Grifols, S.A. analysed technically?
Technical analysis of Grifols, S.A. is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.
Which timeframes are used for Grifols, S.A.?
The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.
What are Elliott Waves applied to Grifols, S.A.?
Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to Grifols, S.A. it helps frame the technical structure of the historical chart and is not a forecast.
Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.
Are you an issuer and want a correction or removal? Write to info@montbon.com.